232 related articles for article (PubMed ID: 14755004)
1. Differential conditioned place preference responses to endomorphin-1 and endomorphin-2 microinjected into the posterior nucleus accumbens shell and ventral tegmental area in the rat.
Terashvili M; Wu HE; Leitermann RJ; Hung KC; Clithero AD; Schwasinger ET; Tseng LF
J Pharmacol Exp Ther; 2004 May; 309(2):816-24. PubMed ID: 14755004
[TBL] [Abstract][Full Text] [Related]
2. (+)-Morphine attenuates the (-)-morphine-produced conditioned place preference and the mu-opioid receptor-mediated dopamine increase in the posterior nucleus accumbens of the rat.
Terashvili M; Wu HE; Schwasinger ET; Hung KC; Hong JS; Tseng LF
Eur J Pharmacol; 2008 Jun; 587(1-3):147-54. PubMed ID: 18448094
[TBL] [Abstract][Full Text] [Related]
3. Endomorphin-2 and endomorphin-1 promote the extracellular amount of accumbal dopamine via nonopioid and mu-opioid receptors, respectively.
Okutsu H; Watanabe S; Takahashi I; Aono Y; Saigusa T; Koshikawa N; Cools AR
Neuropsychopharmacology; 2006 Feb; 31(2):375-83. PubMed ID: 16034447
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical hyperalgesia induced by mu-opioid receptor agonist endomorphin-2, but not endomorphin-1, microinjected into the centromedial amygdala of the rat.
Terashvili M; Wu HE; Schwasinger E; Tseng LF
Eur J Pharmacol; 2007 Jan; 554(2-3):137-44. PubMed ID: 17112504
[TBL] [Abstract][Full Text] [Related]
5. Rewarding and psychomotor stimulant effects of endomorphin-1: anteroposterior differences within the ventral tegmental area and lack of effect in nucleus accumbens.
Zangen A; Ikemoto S; Zadina JE; Wise RA
J Neurosci; 2002 Aug; 22(16):7225-33. PubMed ID: 12177217
[TBL] [Abstract][Full Text] [Related]
6. General, kappa, delta and mu opioid receptor antagonists mediate feeding elicited by the GABA-B agonist baclofen in the ventral tegmental area and nucleus accumbens shell in rats: reciprocal and regional interactions.
Miner P; Shimonova L; Khaimov A; Borukhova Y; Ilyayeva E; Ranaldi R; Bodnar RJ
Brain Res; 2012 Mar; 1443():34-51. PubMed ID: 22305145
[TBL] [Abstract][Full Text] [Related]
7. Differential mechanisms of antianalgesia induced by endomorphin-1 and endomorphin-2 in the ventral periaqueductal gray of the rat.
Terashvili M; Wu HE; Leitermann RJ; Sun HS; Clithero AD; Tseng LF
J Pharmacol Exp Ther; 2005 Mar; 312(3):1257-65. PubMed ID: 15542622
[TBL] [Abstract][Full Text] [Related]
8. Cocaine reward and hyperactivity in the rat: sites of mu opioid receptor modulation.
Soderman AR; Unterwald EM
Neuroscience; 2008 Jul; 154(4):1506-16. PubMed ID: 18550291
[TBL] [Abstract][Full Text] [Related]
9. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
10. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats.
Bals-Kubik R; Ableitner A; Herz A; Shippenberg TS
J Pharmacol Exp Ther; 1993 Jan; 264(1):489-95. PubMed ID: 8093731
[TBL] [Abstract][Full Text] [Related]
11. Opposite conditioned place preference responses to endomorphin-1 and endomorphin-2 in the mouse.
Wu HE; MacDougall RS; Clithero AD; Leitermann RJ; Terashvili M; Tseng LF
Neurosci Lett; 2004 Jul; 365(3):157-61. PubMed ID: 15246539
[TBL] [Abstract][Full Text] [Related]
12. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
13. Induction of conditioned place preference and dopamine release by salsolinol in posterior VTA of rats: involvement of μ-opioid receptors.
Hipólito L; Martí-Prats L; Sánchez-Catalán MJ; Polache A; Granero L
Neurochem Int; 2011 Oct; 59(5):559-62. PubMed ID: 21693150
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide FF attenuates the acquisition and the expression of conditioned place aversion to endomorphin-2 in mice.
Han ZL; Wang ZL; Tang HZ; Li N; Fang Q; Li XH; Yang XL; Zhang XY; Wang R
Behav Brain Res; 2013 Jul; 248():51-6. PubMed ID: 23578757
[TBL] [Abstract][Full Text] [Related]
15. Functional interaction between OX2 and CB1 receptors in the ventral tegmental area and the nucleus accumbens in response to place preference induced by chemical stimulation of the lateral hypothalamus.
Yazdi F; Jahangirvand M; Pirasteh AH; Moradi M; Haghparast A
Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):39-46. PubMed ID: 26494513
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid reward and aversion effects in the posterior ventral tegmental area are mediated through dissociable opiate receptor subtypes and separate amygdalar and accumbal dopamine receptor substrates.
Ahmad T; Laviolette SR
Psychopharmacology (Berl); 2017 Aug; 234(15):2325-2336. PubMed ID: 28669034
[TBL] [Abstract][Full Text] [Related]
17. Accumbal core: essential link in feed-forward spiraling striato-nigro-striatal in series connected loop.
Ikeda H; Koshikawa N; Cools AR
Neuroscience; 2013 Nov; 252():60-7. PubMed ID: 23933312
[TBL] [Abstract][Full Text] [Related]
18. Mesolimbic dopamine neurotransmission is increased by administration of mu-opioid receptor antagonists.
Devine DP; Leone P; Wise RA
Eur J Pharmacol; 1993 Oct; 243(1):55-64. PubMed ID: 7902813
[TBL] [Abstract][Full Text] [Related]
19. Different motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouse.
Narita M; Ozaki S; Ioka M; Mizoguchi H; Nagase H; Tseng LF; Suzuki T
Neuroscience; 2001; 105(1):213-8. PubMed ID: 11483313
[TBL] [Abstract][Full Text] [Related]
20. Intra-VTA injections of the mu-opioid antagonist CTOP enhance locomotor activity.
Badiani A; Leone P; Stewart J
Brain Res; 1995 Aug; 690(1):112-6. PubMed ID: 7496796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
